IN SILICO PREDICTION OF PASS AND ADME/TOX PROPERTIES OF NOVEL 1,3,5-TRIAZINE DERIVATIVES FOR DRUG DEVELOPMENT
1,3,5-Triazines are heterocyclic compounds with diverse pharmacological activities, including anticancer, antimicrobial, anti-inflammatory, and neurotropic effects. This study employs in silico approaches to evaluate the Prediction of Activity Spectra for Substances (PASS) and ADME/Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties of six novel 1,3,5-triazine derivatives. The PASS analysis revealed potential biological activities, such as testosterone-17β-dehydrogenase inhibition, anaphylatoxin receptor antagonism, and neurotropic effects, suggesting applications in oncology, immunology, and neurology. ADME/Tox profiling indicated favorable oral bioavailability for all compounds, with variations in blood-brain barrier penetration, plasma protein binding, and metabolic stability. Toxicity predictions highlighted cardiotoxicity (hERG inhibition), hepatotoxicity, and genotoxic risks, necessitating further experimental validation. These findings provide a computational foundation for the rational design of 1,3,5-triazine-based therapeutics while identifying key pharmacokinetic and safety considerations.
Сведения
- Опубликовано
- 2025 · Т. 4, № 465
- Язык
- Английский
- ISSN
- 2224-5286 · 2518-1491
- Издатель
- Central Asian Academic Research Center LLP